Profil
Michael Molyneaux worked as the Chief Medical Officer at Macrocure Ltd.
from 2013 to 2015.
He holds an MBA from Washington University in St. Louis, a doctorate from Dalhousie University, and an undergraduate degree from the University of Prince Edward Island.
Ehemalige bekannte Positionen von Michael Molyneaux
| Unternehmen | Position | Ende |
|---|---|---|
| MACROCURE LTD | Technik-/Wissenschafts-/F&E-Leiter | 31.12.2015 |
Ausbildung von Michael Molyneaux
| Washington University in St. Louis | Masters Business Admin |
| University of Prince Edward Island | Undergraduate Degree |
| Dalhousie University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Macrocure Ltd.
 Macrocure Ltd. Medical SpecialtiesHealth Technology Macrocure Ltd. is a clinical-stage biotechnology company, which engages in the development and commercialization of advanced cell therapy products. Its product, CureXcell, is an advanced wound care therapy that treat such wounds by injecting living human white blood cells that have been activate to facilitate the healing process. The company was founded by David Ben-Ami on January 14, 2008 and is headquartered in Petach Tikva, Israel. | Health Technology |
